Substance / Medication

Mezlocillin

Overview

Active Ingredient
mezlocillin
RxNorm CUI
6927

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

97 trials linked to this intervention

97
Total Trials
26
Recruiting
8
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants.
Zhou Jing, Jiang Li, Zhang Zhi Ling et al. · J Antimicrob Chemother · 2022
PMID: 35662337Other
Clinical determinants for the recovery of fungal and mezlocillin-resistant pathogens from bile specimens.
Ehrenstein Boris P, Salamon Lea, Linde Hans-Jörg et al. · Clin Infect Dis · 2002
PMID: 11880954Other
In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.
Hunfeld K P, Weigand J, Wichelhaus T A et al. · Int J Antimicrob Agents · 2001
PMID: 11282265Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Mezlocillin (substance)
SNOMED CT
387446008
UMLS CUI
C0025893
RxNorm CUI
6927

Clinical Data

This intervention maps to 11 entities in the Healos knowledge graph.

11
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
97
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.